Variation of Arene Moiety in Ruthenium (II) Arene Halido Complexes of Quinoline and Benzazole‐Derived Ligands: Development and Antiprostate Cancer Potential
Chemistry – An Asian Journal · 2026
DOI: 10.1002/asia.70946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2026. Verfasst von Tanveer A Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Central University of Rajasthan, Ajmer, India. Hauptthemen laut MEDLINE: Ruthenium, Antineoplastic Agents, Quinolines, Coordination Complexes. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science and Engineering Research Board, Ministry of Education, Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
Castration‐resistant prostate cancer (CRPC) is an advanced, treatment‐refractory disease with high mortality and limited therapeutic options, necessitating novel metallodrugs with enhanced potency and reduced toxicity. Herein, we report the design and syntheses of two quinoline–benzazole hybrid bidentate ligands—2‐(1H‐benzo[d]imidazol‐2‐yl)quinoline (L1) and 2‐(quinolin‐2‐yl)benzo[d]thiazol (L2)—along with four new half‐sandwich ruthenium(II) arene chlorido complexes of the general formula [(η 6 ‐arene)(L)RuCl]PF 6 , where arene = benzene (Bz) or hexamethylbenzene (Hmb), yielding complexes 1–4. The ligands and complexes were fully characterized by spectroscopic ( 1 H/ 1 3 C NMR, IR, UV–vis) and analytical methods (elemental analysis, ESI‐MS), with aqueous stability profiles confirming their suitability for biological evaluation. Cytotoxicity assays against the PC‐3 CRPC cell line identified potent antiproliferative activity in selected complexes. Mechanistic studies revealed predominant G2/M phase cell cycle arrest, induction of apoptosis, and moderate‐to‐strong DNA binding affinities suggestive of intercalative/groove‐binding modes. These results highlight the potential of quinoline–benzazole Ru(II) arene scaffolds as promising candidates for CRPC therapy, meriting further optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Central University of Rajasthan, Ajmer, India.
- Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India.
- Department of Applied Chemistry, School of Vocational Studies and Applied Sciences, Gautam Buddha University, Greater Noida, Uttar Pradesh, India.
- School of Chemistry, University of Hyderabad, Hyderabad, Telangana, India.
ORCID-Profile: Tanveer A Khan, Anubha Yadav, Priyal Malpani, Kishalay Bhar, Vinit Kumar, Anuj K Sharma
Förderung
- Science and Engineering Research Board
- Ministry of Education
- Council of Scientific and Industrial Research, India
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Khan, T. A., Yadav, A., Malpani, P., Bhar, K., Kumar, V., & Sharma, A. K. (2026). Variation of Arene Moiety in Ruthenium (II) Arene Halido Complexes of Quinoline and Benzazole‐Derived Ligands: Development and Antiprostate Cancer Potential. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.70946
Vancouver
Khan TA, Yadav A, Malpani P, Bhar K, Kumar V, Sharma AK. Variation of Arene Moiety in Ruthenium (II) Arene Halido Complexes of Quinoline and Benzazole‐Derived Ligands: Development and Antiprostate Cancer Potential. Chemistry – An Asian Journal. 2026. doi:10.1002/asia.70946
BibTeX
@article{Khan2026,
author = {Khan, Tanveer A and Yadav, Anubha and Malpani, Priyal and Bhar, Kishalay and Kumar, Vinit and Sharma, Anuj K},
title = {Variation of Arene Moiety in Ruthenium (II) Arene Halido Complexes of Quinoline and Benzazole‐Derived Ligands: Development and Antiprostate Cancer Potential},
journal = {Chemistry – An Asian Journal},
year = {2026},
doi = {10.1002/asia.70946}
}
EUVIMED